-
Top 10 drugs losing exclusivity in 2019
fiercepharma
March 06, 2019
Pharma companies do their best to fight off patent expirations and generic competition as long as possible to protect their big moneymakers. But this year looks like the end of the line for many of the industry's top brands.
-
Seven Trends of the Pharmaceutical Industry in 2019 (2)
PharmaSources/Zhixing
February 18, 2019
Biosimilar, drug price increase and and more innovative therapies, What will be the trends of the medical world in 2019?
-
Seven Trends of the Pharmaceutical Industry in 2019 (1)
PharmaSources/Zhixing
February 18, 2019
FDA reached a record high in 2018 by approving the marketing of 59 new drugs in total. Then, what will be the trends of the medical world in 2019?
-
Exciting! Which Products Are the Pharmapack Awards Winners of 2019?
en-cphi.cn
February 11, 2019
In June of this year, these latest packaging products from all over the world will come to Shanghai for their first show in Asia.
-
Global Humira sales near $20bn, but expect decline in 2019
bioprocessintl
February 03, 2019
Looking to 2019, AbbVie says US sales of its bestseller monoclonal antibody Humira (adalimumab) will continue to grow but expects a $2 billion hit from biosimilar competition.
-
JP Morgan: no expert consensus on 2019 capital outlook for bio/pharma
pharmaceutical-technology
February 03, 2019
Expert speakers at this year’s JPM Healthcare Conference disagreed in their optimism for capital markets and M&A in 2019.
-
Chinese-produced new drugs to be marketed soon in 2019
PharmaSources/Caicai
January 21, 2019
Chinese-produced new drugs to be marketed soon in 2019
-
What Are the Most Important Acquisitions in 2018?
en-cphi.cn
January 16, 2019
What Are the Most Important Acquisition in 2018?
-
Can China’s R&D sector shake its reputational issues in 2019?
fiercebiotech
December 26, 2018
While 2018 was a big year for Chinese R&D on the whole, the sector hit the headlines for the wrong reasons.
-
GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'
fiercepharma
December 19, 2018
In the face of "unprecedented" demand for its shingles vaccine, GlaxoSmithKline is doing everything it can to boost supply.